U.S., March 13 -- ClinicalTrials.gov registry received information related to the study (NCT06872359) titled 'Evaluation of Performance and Safety of Injectable KIO017 Device Range for Facial Tissue Filling' on Feb. 27.
Brief Summary: The goal of this clinical trial is to primarily evaluate the performance of KIO017 in filling/volumizing after injection in different areas in healthy women or men, older than 18 years and seeking an improvement of her/his face aspect with resorbable filler. The main questions it aims to answer are:
If the products are safe
- Acceptable local tolerance, with acceptable clinical signs after injection.
If the clinical performance is as intended compared to baseline
* Evaluation of performance by assessing t...